Genetic heterogeneity by comparative genomic hybridization in BRCAx breast cancers

Cancer Genetics and Cytogenetics

Volumn 182, Issue 2, 2008, Pages 75-83

  Mangia, Anita ^a   Chiarappa, Patrizia ^a   Tommasi, Stefania ^a   Chiriatti, Annalisa ^a   Petroni, Stella ^a   Schittulli, Francesco ^a   Paradiso, Angelo ^a  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DNA;

ARTICLE; BRCAX GENE; BREAST CANCER; CHROMOSOME 12Q; CHROMOSOME 15Q; CHROMOSOME 19P; CHROMOSOME 1P; CHROMOSOME 2Q; CHROMOSOME 3P; CHROMOSOME 3Q; CHROMOSOME 4P; CHROMOSOME 4Q; CHROMOSOME 5P; CHROMOSOME 6Q; CHROMOSOME 8P; CHROMOSOME 9P; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOGENETICS; DNA DETERMINATION; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; LASER MICRODISSECTION; MOLECULAR CLONING; ONCOGENE; PRIORITY JOURNAL; TUMOR GENE;

ADULT; AGED; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; DNA, NEOPLASM; FEMALE; GENETIC HETEROGENEITY; GENOME, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; MUTATION; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION;

EID: 41749116144     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2008.01.002     Document Type: Article

References (37)

1. Lacroix M., and Leclercq G. The "portrait" of hereditary breast cancer. Breast Cancer Res Treat 89 (2005) 297-304
2. Shugart Y.Y., Cour C., Renard H., Lenoir G., Goldgar D., Teare D., Easton D., Rahman N., Gusterton R., Seal S., Barfoot R., Stratton M., Mangion J., Peelen T., van den Ouweland A., Meijers H., Devilee P., Eccles D., Lynch H., Weber B., Stoppa-Lyonnet D., Bignon Y.J., and Chang-Claude J. Linkage analysis of 56 multiplex families excludes the Cowden disease gene PTEN as a major contributor to familial breast cancer. J Med Genet 36 (1999) 720-721
3. Broeks A., Urbanus J.H., Floore A.N., Dahler E.C., Klijn J.G., Rutgers E.J., Devilee P., Russell N.S., van Leeuwen F.E., and van't Veer L.J. ATM-heterozygous germline mutations contribute to breast cancer-susceptibility. Am J Hum Genet 66 (2000) 494-500
4. Sensi E., Tancredi M., Aretini P., Cipollini G., Naccarato A.G., Viacava P., Bevilacqua G., and Caligo M.A. p53 inactivation is a rare event in familial breast tumors negative for BRCA1 and BRCA2 mutations. Breast Cancer Res Treat 82 (2003) 1-9
5. Meijers-Heijboer H., Wijnen J., Vasen H., Wasielewski M., Wagner A., Hollestelle A., Elstrodt F., van den Bos R., de Snoo A., Fat G.T., Brekelmans C., Jagmohan S., Franken P., Verkuijlen P., van den Ouweland A., Chapman P., Tops C., Möslein G., Burn J., Lynch H., Klijn J., Fodde R., and Schutte M. The CHEK2 1100delC mutation identifies families with hereditary breast and colorectal cancer phenotype. Am J Hum Genet 72 (2003) 1308-1314
6. Xiao-Lei Zhou, Werelius B., and Lindblom A. A screen for germline mutations in the gene encoding CCCTC-binding factor (CTCF) in familial non-BRCA1/BRCA2 breast cancer. Breast Cancer Res 6 (2004) R187-R190
7. Tommasi S., Fedele V., Lacalamita R., Bruno M., Schittulli F., Ginzinger D., Scott G., Eppenberger-Castori S., Calistri D., Casadei S., Seymour I., Longo S., Giannelli G., Pilato B., Simone G., Benz C.C., and Paradiso A. 655Val and 1170Pro ERBB2 SNPs in familial breast cancer risk and BRCA1 alterations. Cell Oncol 29 (2007) 241-248
8. Hedenfalk I.A., Ringnér M., Trent J.M., and Borg A. Gene expression in inherited breast cancer. Adv Cancer Res 84 (2002) 1-34
9. Seitz S., Rohde K., Bender E., Nothnagel A., Kölble K., Schlag P.M., and Scherneck S. Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: linkage analysis in German breast cancer families. Oncogene 14 (1997) 741-743
10. Weaver D., Stephan D., Bailey-Wilson J., Kallioniemi O.P., Tirkkonen M., Syrjäkoski K., Kuukasjärvi T., Koivisto P., Karhu R., Holli K., Arason A., Johannesdottir G., Bergthorsson J.T., Johannsdottir H., Egilsson V., Barkardottir R.B., Johannsson O., Haraldsson K., Sandberg T., Holmberg E., Grönberg H., Olsson H., Borg A., Vehmanen P., Eerola H., Heikkila P., Pyrhönen S., and Nevanlinna H. Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus. Proc Natl Acad Sci U S A 97 (2000) 9603-9608
11. Johnson S.M., Shaw J.A., and Walker R.A. Sporadic breast cancer in young women: prevalence of loss of heterozygosity at p53, BRCA1 and BRCA2. Int J Cancer 98 (2002) 205-209
12. Huusko P., Juo S.H., Gillanders E., Sarantaus L., Kainu T., Vahteristo P., Allinen M., Jones M., Rapakko K., Eerola H., Markey C., Vehmanen P., Gildea D., Freas-Lutz D., Blomqvist C., Leisti J., Blanco G., Puistola U., Trent J., Bailey-Wilson J., Winqvist R., Nevanlinna H., and Kallioniemi O.P. Genome-wide scanning for linkage in Finnish breast cancer families. Eur J Hum Genet 12 (2004) 98-104
13. Gronwald J., Jauch A., Cybulski C., Schoell B., Böhm-Steuer B., Lener M., Grabowska E., Górski B., Jakubowska A., Domagała W., Chosia M., Scott R.J., and Lubiński J. Comparison of genomic abnormalities between BRCAX and sporadic breast cancers studied by comparative genomic hybridization. Int J Cancer 114 (2005) 230-236
14. Isola J., DeVries S., Chu L., Ghazvini S., and Waldman F. Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am J Pathol 145 (1994) 1301-1308
15. Aubele M., Mattis A., Zitzelsberger H., Walch A., Kremer M., Hutzler P., Höfler H., and Werner M. Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization. Cancer Genet Cytogenet 110 (1999) 94-102
16. Tommasi S., Crapolicchio A., Lacalamita R., Bruno M., Monaco A., Petroni S., Schittulli F., Longo S., Digennaro M., Calistri D., Mangia A., and Paradiso A. BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy. Mutat Res 578 (2005) 395-405
17. Cardoso J., Molenaar L., de Menezes R.X., Rosenberg C., Morreau H., Moslein G., Fodde R., and Boer J.M. Genomic profiling by DNA amplification of laser capture microdissected tissues and array CGH. Nucleic Acids Res 32 (2004) e146
18. Rook M.S., Delach S.M., Deyneko G., Worlock A., and Wolfe J.L. Whole genome amplification of DNA from laser capture-microdissected tissue for high-throughput single nucleotide polymorphism and short tandem repeat genotyping. Am J Pathol 164 (2004) 23-33
19. Harada T., Okita K., Shiraishi K., Kusano N., Satoshi K., and Sasaki K. Interglandular cytogenetic heterogeneity detected by comparative genomic hybridization in pancreatic cancer. Cancer Res 62 (2002) 835-839
20. Kirchhoff M., Gerdes T., Rose H., Maahr J., Ottesen A.M., and Lundsteen C. Detection of chromosomal gains and losses in comparative genomic hybridization analysis based on standard reference intervals. Cytometry 31 (1998) 163-173
21. Kirchhoff M., Gerdes T., Maahr J., Rose H., Bentz M., Döhner H., and Lundsteen C. Deletions below 10 megabasepairs are detected in comparative genomic hybridization by standard reference intervals. Genes Chromosomes Cancer 25 (1999) 410-413
22. Kirchhoff M., Rose H., and Lundsteen C. High resolution comparative genomic hybridisation in clinical cytogenetics. J Med Genet 38 (2001) 740-744
23. Rennstam K., Ahlstedt-Soini M., Baldetorp B., Bendahl P.O., Borg A., Karhu R., Tanner M., Tirkkonen M., and Isola J. Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis: a study of 305 tumors by comparative genomic hybridization. Cancer Res 63 (2003) 8861-8868
24. Gebhart E. Comparative genomic hybridization (CGH): ten years of substantial progress in human solid tumor molecular cytogenetics. Cytogenet Genome Res 104 (2004) 352-358
25. Tirkkonen M., Kainu T., Loman N., Jóhannsson O.T., Olsson H., Barkardóttir R.B., Kallioniemi O.P., and Borg A. Somatic genetic alterations in BRCA2-associated and sporadic male breast cancer. Genes Chromosomes Cancer 24 (1999) 56-61
26. Venter D.J., Ramus S.J., Hammet F.M., de Silva M., Hutchins A.M., Petrovic V., Price G., and Armes J.E. Complex CGH alterations on chromosome arm 8p at candidate tumor suppressor gene loci in breast cancer cell lines. Cancer Genet Cytogenet 160 (2005) 134-140
27. Yamamoto K., Nagata K., Tsurukubo Y., Inagaki K., Ono R., Taki T., Hayashi Y., and Hamaguchi H. Translocation (8;12)(q13;p13) during disease progression in acute myelomonocytic leukemia with t(11;19)(q23;p13.1). Cancer Genet Cytogenet 137 (2002) 64-67
28. Parrella P., Scintu M., Prencipe M., Poeta M.L., Gallo A.P., Rabitti C., Rinaldi M., Tommasi S., Paradiso A., Schittulli F., Valori V.M., Toma S., Altomare V., and Fazio V.M. HIC1 promoter methylation and 17p13.3 allelic loss in invasive ductal carcinoma of the breast. Cancer Lett 222 (2005) 75-81
29. Maguire P., Holmberg K., Kost-Alimova M., Imreh S., Skoog L., and Lindblom A. CGH analysis of familial non-BRCA1/BRCA2 breast tumors and mutation screening of a candidate locus on chromosome 17q11.2-12. Int J Mol Med 16 (2005) 135-141
30. Johannsdottir H.K., Johannesdottir G., Agnarsson B.A., Eerola H., Arason A., Johannsson O.T., Heikkilä P., Egilsson V., Olsson H., Borg A., Nevanlinna H., and Barkardottir R.B. Deletions on chromosome 4 in sporadic and BRCA mutated tumors and association with pathological variables. Anticancer Res 24 (2004) 2681-2687
31. Tirkkonen M., Johannsson O., Agnarsson B.A., Olsson H., Ingvarsson S., Karhu R., Tanner M., Isola J., Barkardottir R.B., Borg A., and Kallioniemi O.P. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res 57 (1997) 1222-1227
32. Dallery-Prudhomme E., Roumier C., Denis C., Preudhomme C., Kerckaert J.P., and Galiègue-Zouitina S. Genomic structure and assignment of the RhoH/TTF small GTPase gene (ARHH) to 4p13 by in situ hybridization. Genomics 43 (1997) 89-94
33. Preudhomme C., Roumier C., Hildebrand M.P., Dallery-Prudhomme E., Lantoine D., Laï J.L., Daudignon A., Adenis C., Bauters F., Fenaux P., Kerckaert J.P., and Galiègue-Zouitina S. Nonrandom 4p13 rearrangements of the RhoH/TTF gene, encoding a GTP-binding protein, in non-Hodgkin's lymphoma and multiple myeloma. Oncogene 13 19 (2000) 2023-2032
34. Karlsson E., Danielsson A., Delle U., Olsson B., Karlsson P., and Helou K. Chromosomal changes associated with clinical outcome in lymph node-negative breast cancer. Cancer Genet Cytogenet 15 172 (2007) 139-146
35. Jacobsen A., Arnold N., Weimer J., and Kiechle M. Comparison of comparative genomic hybridization and interphase fluorescence in situ hybridization in ovarian carcinomas: possibilities and limitations of both techniques. Cancer Genet Cytogenet 122 (2000) 7-12
36. Rao U.N.M., Gollin S.M., Beaves S., Cieply K., Nalesnik M., and Michalopoulos G. Comparative genomic hybridization of hepatocellular carcinoma: correlation with fluorescence in situ hybridization in paraffin-embedded tissue. Mol Diagn 8 (2001) 27-37
37. Duesberg P., Li R., Fabarius A., and Hehlmann R. The chromosomal basis of cancer. Cell Oncol 27 (2005) 293-318